Keywords: novartis, myfortic, completes, eu, mrp, swiss, drug

Novartis' Myfortic completes EU's MRP

Article | 16 February 2004

Swiss drug major Novartis has revealed that its application for the enteric-coated immunosuppressant Myfortic (mycophenolate sodium) has successfully completed the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Mycophenolic Acid

Myfortic

Cyclosporine

Neoral

Go to drug listing